Honolulu—Although macrolide antibiotics do not reduce mortality in people with acute exacerbations of chronic obstructive pulmonary disease, they do help delay readmission and might reduce costs, according to a University of Colorado study.
The study aimed to determine whether the immunomodulatory and anti-inflammatory effects of macrolide antibiotics make them more effective than other classes of antibiotics. Antibiotics are a primary form of treatment for severe